USPTO serial 79200076
AGANTRYS
Reviewed by CopyMark Law Group
Reg. 5202476Status 709
- Filing date
- Status date
- Registration date
- May 16, 2017
- Examiner
- SABLE, ERIC
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AGANTRYS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks in Class 005
- Similar marks named AGANTRYS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 2, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 31, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 10, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 10, 2024 | INPC | INVALIDATION PROCESSED | — |
| Aug 2, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 1, 2023 | C71T | CANCELLED SECTION 71 | — |
| Jul 3, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 23, 2018 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED | — |
| Jul 14, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 24, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 24, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 15, 2017 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| May 16, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 11, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 28, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 22, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 22, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 8, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 28, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 24, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 24, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 24, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 23, 2017 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 12, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |